and Neurocrine Biosciences/Nxera Pharma's muscarinic M4 agonist NBI-1117568, which recently cleared a phase 2 study. Another hopeful, Otsuka's TAAR1 agonist ulotaront, failed phase 3 testing ...
Send us a tip using our anonymous form. A daily briefing on what matters in the music industry Send us a tip using our anonymous form.
As of 1:34:27 pm SGT. Market open. Loading Chart for Z77.SI ...
After hours: March 12 at 6:24:06 PM EDT Loading Chart for NBIX ...
After hours: March 7 at 4:05:09 PM EST Loading Chart for OBIO ...
MALAYSIA: A food delivery rider in Malaysia recently proved that kindness knows no bounds when… ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback